Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Amplitech Reports 2Q Results; Emerges from Covid-19 Ready for Growth
-
Amplitech Reports 2Q Results; Emerges from Covid-19 Ready for Growth
-
Natural Gas Services (NGS) PT Raised to $12 at Maxim Group, Following Earnings
-
CHF Solutions Inc. (CHFS) Prices of $12.5 Million Underwritten Public Offering of Common Stock, Warrants
-
CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering
-
Chesapeake Utilities (CPK) Announces Proposed $75M At-the-Market Share Offering Program
-
Seanergy Maritime (SHIP) Prices 35.7M Unit Offering at $0.70/Unit
-
Seanergy Maritime Holdings Corp. Announces Pricing of $25.0 Million Underwritten Public Offering
-
Chesapeake Utilities Corporation Announces $75 Million At-The-Market Equity Offering Program
-
Newgioco Group Announces Closing of $10.0 Million Underwritten Public Offering
-
Seanergy Maritime (SHIP) Announces Public Offering of Common Shares and Warrants
-
Seanergy Maritime Holdings Corp. Announces Public Offering of Common Shares and Warrants
-
Maxim Group Downgrades Titan Pharmaceuticals (TTNP) to Hold, Following Earnings
-
Kubient Announces Exercise of Overallotment Option and Closing of Initial Public Offering
-
Urban Tea (MYT) Prices 18.8M Share Registered Direct Offering at $0.32/Sh
-
Urban Tea, Inc. Announces Pricing of $6.0 Million Ordinary Share Registered Direct Offering
-
VerifyMe Reports Second Quarter 2020 Results
-
VerifyMe Reports Second Quarter 2020 Results
-
NTN Buzztime (NTN) and Brooklyn ImmunoTherapeutics LLC Enter into Definitive Merger Agreement
-
NTN Buzztime, Inc. and Brooklyn ImmunoTherapeutics LLC Enter into Definitive Merger Agreement
-
Newgioco Group (NWGI) Prices 4.167M Unit Common Offering at $2.40/Unit
-
Newgioco Group Announces Pricing of $10.0 Million Underwritten Public Offering
-
Kubient (KBNT) Prices 2.5M Unit Upsized IPO at $5/Unit
-
Kubient Announces Pricing of Upsized $12.5 Million Initial Public Offering
-
Leading Innovators in Women’s Health Presented by Maxim Group LLC on August 13, 2020
-
4 Penny Stocks To Buy For Under $4 For Now
-
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
-
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
-
Digerati Engages Maxim Group LLC to Assist with its Growth Strategy and Goal to Up-List to a National Exchange
-
Prime Trust Hires World-Class Executives as Hyper-Growth Continues
-
SINTX Technologies Announces Closing of $8.2 Million Registered Direct Offering
-
SINTX Technologies Announces Closing of $8.2 Million Registered Direct Offering
-
VistaGen Therapeutics Announces Exercise and Closing of Underwriters' Over-allotment Option in Underwritten Public Offering
-
Capricor Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
Daré Bioscience CEO to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
-
VistaGen Therapeutics Announces Closing of $12.5 Million Underwritten Public Offering
-
Aptose Biosciences (APS:CN) (APTO) PT Lowered to $12 at Maxim Group, Following Earnings
-
Hot Penny Stocks To Buy Right Now According To Analysts
-
SINTX Technologies (SINT) Prices 3.415M Share Registered Direct Offering at $2.40/Sh
-
SINTX Technologies Announces Pricing of $8.2 Million Registered Direct Offering Priced At-The-Market
-
SINTX Technologies Announces Pricing of $8.2 Million Registered Direct Offering Priced At-The-Market
-
Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer
-
Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer
-
Can You Make Money In Penny Stocks? 3 To Wach Right Now
-
VistaGen Therapeutics (VTGN) Prices 15.625M Share Common Offering at $0.80/Sh
-
VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
-
Looking For Penny Stocks To Buy? Here's What Analysts Think
-
VistaGen Therapeutics (VTGN) Commences Public Offering of Common Stock
-
VistaGen Therapeutics Announces Proposed Public Offering of Common Stock
-
SELLAS Life Sciences Announces $9.2 Million Private Placement Priced At-The-Market

